« août 2019 »
L M M J V S D
29 30 31 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31 1
 
Tous les évènements de Physique à venir

Tous les évènements de Biologie / Chimie à venir

Tous les évènements à venir

Les évènements relevant de la Physique et de la Biologie / Chimie sont représentés en turquoise

HSP70 - EXOSOMES IN CANCER THERANOSTICS

Mardi 4 décembre 2018 11:00 - Duree : 1 heure
Lieu : Salle de Conférence de l’IAB - Rond Point de La Chantourne, 38700 La Tronche (arrêt de tram Grand Sablon, ligne B)

Orateur : Carmen GARRIDO (University of Burgundy, Dijon)

Exosomes are extracellular vesicles ( 50–200 nm) released into the extracellular environment via the endosomal vesicle pathway by fusion with the plasma membrane. We have demonstrated that cancer cells, but not “normal” cells, release exosomes expressing the heat shock protein-70 (HSP70) in their membrane. This extracellular HSP70 through its association to the toll-receptor 2 on myeloid-derived suppressive cells can block the development of an efficient anticancer immune response (Chalmin et al JCI 2010 ; Arlet, Nature 2014 ; Gobbo et al, JNCI 2016 ; Busdesco et al, Blood 2018). Therefore, the inhibition of HSP70-exosomes is an interesting strategy in cancer therapy. Since one single cancer cell can release thousands of HSP70-exosomes, detection of those cancerderived exosomes should be an important step toward early cancer detection. To capture HSP70- exosomes from human fluids, we have set up an innovative interference biolayer approach using as a high affinity ligand a HSP70 peptide aptamer that we have selected by its ability to specifically bind the extracellular domain of membrane-bound HSP70 (Patents 2016-8). We have opened a 3-years prospective study called ExoDiag with the anticancer center Georges François Leclerc (inclusion of patients started in 2016). ExoDiag will include 60 patients with newly diagnosed cancer (n=15 nonmetastatic breast ; n=15 metastatic breast, n=20 metastatic lung and n=10 metastatic ovary) and 20 controls. Results analyzed so far indicated that 1) HSP70-exosomes are markers of tumor dissemination : their level is very high in metastatic patients compared to patients with primary tumors or healthy volunteers ; 2) HSP70-exosomes are detected much earlier than circulating tumor cells (determined by CellSearch) ; 3) there seems to be a cancer-type specific miRNA (small non-coding RNAs) signature in these circulating HSP70-exosomes that can inform us the cellular origin of the HSP70-exosome and thereby of the metastasis. These results will be translated in an earlier and adapted care and management of the patient.

Contact : karin.sadoul@univ-grenoble-alpes.fr

Discipline évènement : (Biologie / Chimie)
Entité organisatrice : (IAB)
Nature évènement : (Séminaire)
Evènement répétitif : (Conférence du GIRC)
Site de l'évènement : Pôle Santé / La Tronche

Prévenir un ami par email

Télécharger dans mon agenda

Cafés sciences de Grenoble | UdPPC de Grenoble | Sauvons Le Climat | Cafe des sciences de Vizille
Accueil du site | Secretariat | Espace privé | Suivre la vie du site RSS 2.0 : Tous les evenements Suivre la vie du site RSS 2.0 : Evenements de Physique Suivre la vie du site RSS 2.0 : Evenements de Biologie & Chimie